Greenleaf Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,405
Closed -$2.62M 592
2019
Q3
$2.62M Sell
26,405
-1,401
-5% -$133K 0.04% 82
2019
Q2
$2.57M Sell
27,806
-61,168
-69% -$5.81M 0.04% 86
2019
Q1
$8.39M Sell
88,974
-263
-0.3% -$23K 0.14% 40
2018
Q4
$5.72M Sell
89,237
-7,996
-8% -$590K 0.11% 46
2018
Q3
$8.7M Buy
97,233
+2,827
+3% +$250K 0.16% 37
2018
Q2
$7.5M Buy
94,406
+1,720
+2% +$143K 0.14% 40
2018
Q1
$8.27M Buy
92,686
+3,845
+4% +$369K 0.16% 31
2017
Q4
$9.27M Sell
88,841
-2,052
-2% -$232K 0.19% 24
2017
Q3
$13.3M Sell
90,893
-3,241
-3% -$441K 0.29% 12
2017
Q2
$12.2M Sell
94,134
-6,172
-6% -$756K 0.28% 13
2017
Q1
$12.5M Sell
100,306
-17,450
-15% -$2.09M 0.3% 14
2016
Q4
$13.6M Sell
117,756
-11,205
-9% -$1.25M 0.36% 12
2016
Q3
$13.5M Buy
128,961
+4,321
+3% +$468K 0.35% 11
2016
Q2
$12.3M Sell
124,640
-112,000
-47% -$11.6M 0.31% 15
2016
Q1
$23.7M Sell
236,640
-13,996
-6% -$1.44M 0.64% 4
2015
Q4
$30M Sell
250,636
-8,389
-3% -$971K 0.91% 2
2015
Q3
$28M Sell
259,025
-2,705
-1% -$336K 0.84% 2
2015
Q2
$30.3M Buy
261,730
+2,115
+0.8% +$242K 0.87% 2
2015
Q1
$29.9M Sell
259,615
-4,772
-2% -$570K 0.9% 2
2014
Q4
$29.6M Sell
264,387
-6,048
-2% -$638K 0.86% 2
2014
Q3
$25.6M Sell
270,435
-1,179
-0.4% -$106K 0.85% 3
2014
Q2
$23.3M Buy
271,614
+6,888
+3% +$524K 0.74% 5
2014
Q1
$18.5M Buy
264,726
+59,662
+29% +$4.72M 0.59% 12
2013
Q4
$17.3M Sell
205,064
-20,118
-9% -$1.59M 0.6% 13
2013
Q3
$17.4M Sell
225,182
-2,224
-1% -$156K 0.65% 10
2013
Q2
$13.3M Buy
+227,406
New +$13.7M 0.52% 9

Other funds holding CELG

Greenleaf Trust's CELG Position: Q4 2019 in Review

Greenleaf Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 26,405 shares — an estimated $2.62M sold.

Greenleaf Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $30.3M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Greenleaf Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Greenleaf Trust sold 26,405 Celgene Corp shares in Q4 2019, an estimated $2.62M.
  • Greenleaf Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Greenleaf Trust's Celgene Corp position peaked at $30.3M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Greenleaf Trust's 13F filing for Q4 2019, filed 11 Feb 2020.